ALVINE PHARMACEUTICALS, INC.;THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
发明人:
申请号：
EP05714080.8
公开号：
EP1740197B1
申请日:
2005.02.23
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
